PLIVA's Press Center is a complete listing of all PLIVA issued news items.
Should you have any questions about PLIVA or are a journalist requiring more information on PLIVA, please contact PLIVA's Communications department.

CONTACT

      

 

DEPARTMENT:		Corporate Communications
E-MAIL:		contact form
PHONE.:		+ 385 1 61 20 909 + 385 1 61 20 612 + 385 1 61 14 413 (fax)
ADDRESS:		PLIVA d.d., Ulica grada Vukovara 49, 10000 Zagreb, Croatia

PLIVA's Press Releases, presentations and publications are all provided as downloads in pdf format. If you do not have the Adobe Acrobat reader® click here to download your FREE copy.

Latest Press releases Press release Archive

PLIVA Announces Changes in its Management Board PLIVA d.d. announced today that Željko Čović, President of the Management Board of PLIVA d.d. and Chief Operating Officer, decided to leave the company and pursue his career elsewhere due to personal reasons. Mr. Čović resigned from his position of the President of the Management Board, effective December 31, 2008, at the meeting of the Supervisory Board held on December 29, 2008. // 12/30/08 PLIVA Notes Teva's Announcement on Completion of Acquisition of Barr PLIVA d.d. (ZSE: PLVA-R-A) notes announcement made by Teva Pharmaceutical Industries Ltd. that that it has completed its acquisition of Barr Pharmaceuticals, Inc., which is enclosed with this announcement. // 12/23/08 TEVA COMPLETES ACQUISITION OF BARR -- Transaction Extends Teva’s Leadership in the U.S. and Key Global Markets; Strengthens Balance Business Model and Enhances Growth Potential -- // 12/23/08 PLIVA Notes Barr Announcements on Clearance by the U.S. Federal Trade Commission and the European Commission of Teva's Acqusition of Barr PLIVA d.d. (ZSE: PLVA-R-A) notes announcements made by Barr Pharmaceuticals, Inc. that the U.S. Federal Trade Commission and the European Commission approved Teva's acquisition of Barr, which are enclosed with this announcement. // 12/22/08 PLIVA Notes Barr Announcement on Barr Shareholders' Approval of Pending Teva Acquisition PLIVA d.d. notes announcement made by Barr Pharmaceuticals, Inc. that Barr shareholders approved pending Teva acquisition, which is enclosed with this announcement. // 11/24/08 PLIVA Announces Nine Month 2008 Results PLIVA d.d. (ZSE: PLVA-R-A), a subsidiary of Barr Pharmaceuticals, Inc. (“Barr”), today reported financial results for the nine month period ended 30 September 2008, prepared in accordance with International Financial Reporting Standards (IFRS). // 11/07/08 PLIVA to Announce 2008 Nine Month Financial Results on 07 November 2008 PLIVA d.d. announced today that a meeting of PLIVA’s Management and Supervisory Boards regarding its financial results for the nine month period ended 30 September 2008 will be held on 06 November 2008, following which PLIVA's 2008 nine month financial results will be released. // 10/31/08 PLIVA Announces Results of Annual General Shareholders' Meeting Held Today PLIVA d.d. (ZSE: PLVA-R-A; “PLIVA” or “the Company”) announces that the Company’s Annual General Shareholders' Meeting that was held in Zagreb today, 26 August 2008, made the following resolutions: // 08/26/08 PLIVA Announces H1 2008 Results PLIVA d.d. (ZSE: PLVA-R-A), a subsidiary of Barr Pharmaceuticals, Inc. (“Barr”), today reported financial results for the six month period ended 30 June 2008, prepared in accordance with International Financial Reporting Standards (IFRS). // 08/08/08